Abstract:
Objective To explore the role of preoperative nutritional and inflammatory indicators, including prognostic nutritional index (PNI), systemic immune-inflammation index (SII), platelet to lymphocyte ratio (PLR), and neutrophil to lymphocyte ratio (NLR) in predicting the prognosis of patients undergoing gastric cancer radical surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC).
Methods A total of 102 patients who underwent gastric cancer radical surgery combined with HIPEC at the Affiliated Hospital of Xuzhou Medical University from January 2020 to December 2021 were selected, and their clinical data were collected for retrospective analysis. Receiver operating characteristic (ROC) curves were plotted to determine the optimal cutoff values for PNI, SII, PLR, and NLR. The patients were divided into groups based on these cutoff values. Kaplan-Meier survival analysis was performed to analyze the overall survival of different groups, and Cox regression analysis was conducted to identify factors influencing the prognosis of gastric cancer patients.
Results A total of 102 patients were included in this study, aged between 33 and 81 years, with 70 males and 32 females. ROC curve analysis determined the optimal cutoff values for each indicator: PNI=45.05, SII=574.5, PLR=160.7, and NLR=2.501. Based on these cutoff values, the patients were divided into two groups: a low-risk group (with 0-2 high-risk indicators,
n=59) and a high-risk group (with 3-4 high-risk indicators,
n=43). The 3-year overall survival rates for the low-risk and high-risk groups were 76.2% and 25.6%, respectively (
P<0.000 1). Multivariate Cox regression analysis showed that lymph node metastasis, and high risk in PNI, SII, PLR, and NLR combined assessment were independent prognostic factors for gastric cancer patients undergoing radical surgery combined with HIPEC.
Conclusions The combined use of PNI, SII, PLR, and NLR in assessing the prognosis of gastric cancer patients undergoing radical surgery combined with HIPEC provides a higher predictive efficacy. This combined scoring system can provide valuable reference for clinical decision-making regarding individualized treatment and postoperative follow-up strategies for gastric cancer patients.